Imiquimod for the treatment of actinic keratosis : a review of clinical effectiveness and cost-effectiveness /
The purpose of this review is to compare the clinical effectiveness and cost-effectiveness of imiquimod (IMQ) compared to other treatment modalities for the treatment of actinic keratosis (AK). This report is the second in the series of three reports on IMQ. The first report was on basal cell and sq...
Saved in:
| Online Access: |
http://www.ncbi.nlm.nih.gov/books/NBK525931/ Full text |
|---|---|
| Main Authors: | , |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Ottawa :
Canadian Agency for Drugs and Technologies in Health,
2017
|
| Edition: | Version 1.0. |
| Series: | Rapid response report (Canadian Agency for Drugs and Technologies in Health)
|
| Subjects: |
